高级检索
当前位置: 首页 > 详情页

Heat shock factor 2 is associated with the occurrence of lung cancer by enhancing the expression of heat shock proteins

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500 [2]Cadres Treatment Section,The First People's Hospital of Yunnan Province, Kunming, Yunnan 510032 [3]Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan 510032 [4]Cadres Health Care, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
出处:
ISSN:

关键词: lung cancer heat shock factor 2 heat shock protein 27 heat shock protein 90

摘要:
Cancer is the leading cause of morbidity and mortality worldwide, particularly lung cancer. Heat shock proteins and their upstream heat shock factors are involved in the occurrence of cancer and have been widely researched. However, the role of heat shock factor 2 (HSF2) in lung cancer remains unclear. In the present study, expression levels of HSF2 in lung cancer tissues from 50 lung cancer patients were detected by reverse transcription quantitative polymerase chain reaction, and 76% (38/50) were upregulated compared with the matched normal tissues. This suggested possible involvement of HSF2 in lung cancer. To additionally investigate the role of HSF2 in lung cancer occurrence, a plasmid encoding HSF2 was constructed. HSF2 was over expressed in normal lung epithelial BEAS-2B cells and lung cancer A549 cells. The results showed that HSF2 overexpression promoted cell proliferation and cell migration in BEAS-2B and A549 cells. Additional experiments showed that the HSF2-induced cell proliferation and cell migration were dependent on induction of HSPs, particularly HSP27 and HSP90, as co-transfection of HSP27 small interfering RNA (siRNA) or HSP90' siRNA attenuated HSF2-induced cell growth and migration. In conclusion, the present study showed that HSF2 is aberrantly expressed in lung cancer, and it may be an upstream regulator of HSPs, which may strongly affect cell growth and cell migration. Additional studies are required to explain the detailed mechanism between lung cancer, HSF2, HSPs and other possible signaling pathways.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q4 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500 [2]Cadres Treatment Section,The First People's Hospital of Yunnan Province, Kunming, Yunnan 510032
通讯作者:
通讯机构: [1]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan 650500 [3]Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan 510032 [*1]Thoracic Surgery, The First People's Hospital of Yunnan Province, 57 Jinbi Road, Kunming, Yunnan 510032, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号